Filipino cancer patients can now access one of the world’s most advanced radiotherapy technologies without traveling overseas after St. Luke’s Medical Center–Quezon City unveiled the country’s first and only TrueBeam Edge system, raising the bar for precision cancer treatment in the Philippines.
Developed by Varian Medical Systems, the next-generation radiotherapy platform combines high-resolution imaging, real-time tumor tracking, motion management and precise patient positioning to deliver radiation with sub-millimeter accuracy. The technology allows oncologists to target tumors more precisely while minimizing radiation exposure to surrounding healthy tissue, potentially reducing side effects and improving treatment outcomes.
The system also shortens treatment sessions through RapidArc volumetric modulated arc therapy, while respiratory gating synchronizes radiation delivery with a patient’s breathing—an important advancement for treating cancers in moving organs such as the lungs and liver.
TrueBeam Edge is likewise equipped with HyperArc stereotactic radiosurgery for complex brain tumors and stereotactic body radiotherapy for difficult-to-treat cancers, procedures that have previously led some Filipino patients to seek specialized treatment abroad.
Hospital officials said the acquisition positions St. Luke’s among a select group of cancer centers worldwide offering the platform, reflecting the growing sophistication of oncology care in the Philippines.
The investment also highlights a broader trend in Philippine healthcare, where leading private hospitals are increasingly adopting precision medicine and cutting-edge medical technologies once available only in major international centers. As cancer cases continue to rise, expanding access to advanced treatment platforms locally could help reduce medical travel, improve clinical outcomes and strengthen the country’s capacity to deliver world-class cancer care.
